SIRPA and neoplasm: Here we introduce several NP-based strategies that target TAMs for suppressing tumor progression: (1) TAMs depletion; (2) inhibiting monocyte recruitment; (3) TAM reprogramming; and (4) blocking CD47- SIRPα signaling (Figure 1, Table 2) [34,35].